Search 

The Center for Biotechnology and Bioengineering is created in 2014, after being selected by the Research Partnership Program of CONICYT to be part of the national program for Basal Funding for Excellence Scientific and Technological Centers.

CeBiB is a Centre of Excellence in cutting-edge research composed by an interdisciplinarian team of renowned national and international scientits, capable of investigating key aspects and current trens in biotechnology and bioengineering, including the research for important applications for industry.

One of the main goals of CeBiB is the research and development of applications to be used in areas where Chile has significant comparative advantages, looking for these areas always in line with the interests of the industry and the needs of the public and private sectors, to increase the competitiveness of the national economy based on scientific and technological innovation.

CeBiB is composed by researchers and academics leaders in their fields from Chilean universities: Universidad de Chile, Universidad de Antofagasta, Universidad de Santiago de Chile, Universidad de La Frontera and Universidad de Los Lagos.

As one of the top universities in Asia-Pacific, The Chinese University of Hong Kong (CUHK) is committed to knowledge transfer and seeks to foster partnerships to commercialise our university’s technologies in the best way to benefit both industry and society. In this regard, CUHK is continuously looking for potential partners/licensees in our below areas of biomedical technologies:

(1)   Therapeutics: Digestive Cancer / Diabetes / Liver Cancer / Neurological Disorders / Orthopaedic and Traumatological Disorders / Pluripotent Stem Cells (see https://goo.gl/Ozm5Gz)

(2)   Diagnostics: Cardiovascular Disorders / Digestive Cancers / Diabetes & its Comorbidities / Gynecology and Obstetrics / Orthopaedic & Traumatological Disorders / Wearables (see https://goo.gl/gcbdLF)

(3) Robotics: Surgical Robots / Endoscopes for Minimally Invasive Surgery and Diagnostic Purposes (see https://goo.gl/TrQSrz) 

Korea Trade Investment Promotion Agency, otherwise known as KOTRA, operates under South Korea's Ministry of Trade, Industry & Energy (MOTIE), as the national trade and investment promotion organization.  KOTRA is a governmental, non-profit agency which promotes and facilitates bilateral business relationships between Korea and the world since its foundation in 1962.

Since inception, KOTRA has facilitated Korea's rapid, export-led economic development through various trade promotion activities such as SME export promotion, trade info services, government-to-government export, foreign investment in Korea (FDI) promotion, and business matchmaking. KOTRA maintains over 120 offices in 82 countries with 13 in South Korea alone. 

I am currently co-leading North America's Startup GP program. A collaboration project between KOTRA's Global Partnering and Overseas Startup Assistance Program. This effort is a part of Korean President Park Geun-hye's "Creative Economy" policy designed to help promising Korean startups connect with leading Corporate Venture Capital firms in the US for potential partnership and investment opportunities.

Lastly, I am the Head of Medical GP. Connect US based Medical and Pharmaceutical companies with Korean counterparts and implement R&D projects, which are co-funded by the Korean government, and I.P. licensing.